First Trust Indxx Medical Devices ETF
MDEV
5 hedge funds and large institutions have $976K invested in First Trust Indxx Medical Devices ETF in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
0.39% more ownership
Funds ownership: 50.96% → 51.36% (+0.39%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
9% less capital invested
Capital invested by funds: $1.07M → $976K (-$92.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$64.4K |
| 2 |
KFAS
Keating Financial Advisory Services
Manhattan,
Kansas
|
+$5.11K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$184 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$61.6K |
MDEV Hedge Fund Activity: Q1 2026 in Review
5 of the 8,160 institutional investors tracked by Wall St. Rank reported a position in First Trust Indxx Medical Devices ETF (MDEV) for Q1 2026, worth a combined $976K — down 8.7% from $1.07M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new MDEV positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, adding an estimated $64.4K. The largest seller was Virtu Financial, cutting an estimated $61.6K.
- 5 institutional investors held First Trust Indxx Medical Devices ETF (MDEV) as of Q1 2026, up from 3 in Q4 2025.
- Funds reported $976K of First Trust Indxx Medical Devices ETF stock for Q1 2026, down 8.7% quarter-over-quarter.
- 2 funds opened new First Trust Indxx Medical Devices ETF positions in Q1 2026 and 0 closed out, a net change of +2 holders.
- The largest First Trust Indxx Medical Devices ETF buyer in Q1 2026 was Jane Street, an estimated $64.4K added.
- The largest First Trust Indxx Medical Devices ETF seller in Q1 2026 was Virtu Financial, an estimated $61.6K sold.
Based on aggregated 13F filings for Q1 2026.